Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction and Chemoradiation for Advanced NPC
NCT00896181Phase 2Completed
- Sponsor
- Stanford University
- Start
- Dec 2008
- Primary completion
- Jan 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by Stanford University. Started Dec 2008; status: completed.
02
Drugs
docetaxelCisplatin micelle injection (HA132)fluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00896181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896181.